IMMUNO-HISTO-CHEMISTRY
Introduction:
Immunohistochemistry (IHC) refers to the process of
detecting antigens in cells of a tissue section by using principle of
antigen-antibody reactions. Immunohistochemical staining is widely used in the
diagnosis of abnormal cells such as those found in cancerous tumors. Specific
molecular markers are characteristics of particular cellular events such as
proliferation or apoptosis. IHC is widely used in basic research to understand
the distribution and localization of biomarkers and differentially expressed
proteins in different parts of a biological tissue.
Albert Coons conceptualized and first implement the
procedure in 1941
Visualizing and antigen-antibody reaction can be
accomplished in a number of ways. Mainly either of the following:
1. Chromogenic
Immunohistochemistry (CIHC): An antibody is conjugated to an enzyme, that can
catalyse a colour producing reaction.
2. Immunofluorescence:
The antibody is tagged to a fluorophore such as fluorescein or rhodamine.
Purpose:
1. IHC can be
used to detect mutations in genes that are associated with the development of
breast cancer and the risk of developing breast cancer.
2. IHC can
also detect HER2 hormone receptor on the tumor surface. Which rates in on a
scale from 0-3+.
3. IHC used
to identify replicating cells. Locate cells that are signalling and also helps
to locate apoptic cells.
4. IHC
identify the different types of cells in a tissue and detect cellular antigen. Also,
it examines the cytoskeletal structure.
Standard IHC Staining Procedure:
1. 3μm Thick
sections are mounted on slides coated with adhesives and fixed in incubator for
overnight at 37°C or
incubated at 60°C for 1hr.
2. Deparaffinize
sections in xylene and grades of alcohol to water.
3. Quench
endogenous peroxidase activity. Incubate slide in hydrogen peroxide block for
10 minutes.
4. Rinse in
buffer wash foe 5 minutes.
5. Perform
antigen retrieval step as desired either using enzymes or heat mediated
protocols.
6. Rinse in
buffer wash for % minutes.
7. Incubate
with primary “blocking serum” for 5 minutes.
8. Rinse
buffer wash. This step can be optional.
9. Incubate
with primary antibody for 1hr at room temperature.
10. Rinse in
buffer wash for 10 minutes. (2 changes of 5 min each)
11. Incubate
with secondary link antibody for 20 to 30 minutes
12. Rinse in
buffer wash for 10 minutes.
13. Apply
chromogen substrate for 5 to 10 minutes.
14. Rinse in
distilled water for 5 minutes.
15. Counter
stain with hematoxylin.
16. Rinse in
running tap water.
17. Dehydrate,
clean and coverslip using DPX.
Staining protocol
for frozen section:
1. Snap
freeze small pieces of tissue.
2. Cut frozen
sections at 4 microns.
3. Pic up
sections on gelatine chrome coated or PLL coated slide.
4. Airdry
overnight at room temperature (25°C -30°C)
5. Fix in
cold acetone for 20 minutes.
6. Air dry
sections.
7. Proceed
with immune-staining.
For frozen section endogenous peroxidase blocking is not
recommended but the use of negative control for the identification of
endogenous peroxidase is preferred.

Immunohistochemistry Staining Procedure:
Sample Preparation: Proper preparation of the sample is critical to maintain cell morphology,tissue architecture and the antigenicity of target epitopes, depending on the purpose and the objective, thickness of the tissue is determined. About 4-40μm slicing of tissue is obtain by microtome and mounting on slides. After preparation of sample or slices, the slices deparaffinize in xylene and ascending grades of alcohol to water. Due to fixation and specimen preservation, additional steps are required to make the specific cell epitopes available for antibody binding. Similarly depending on the tissue type and the method of antigen detection endogenous enzymes may need to be blocked.
Selection of
paraffin Block: After ample fixation we need to prepare paraffin block
of the sample. We use sometime frozen section prepared by cryostat or any other
mechanism. Depending on the tissue. We use various temperature for preparation
of paraffin block.
Sectioning and Deparaffinization: After the preparation of paraffin block or frozen section, with the help of microtome tissue sectioning is done and then the deparaffinization process of tissue by xylene and ascending grades of alcohol to water. After that the deparaffinized tissue is induced to perform further procedure of IHC that is blocking of endogenous enzymes.
Blocking of Endogenous Enzymes: Before the deparaffinization process we should mount the slide with adhesives poly-l-lysine in an incubator for overnight at 37°C. The next method for blocking of endogenous enzymes we should quench endogenous peroxidase activity and incubate the slide in hydrogen peroxide block for 10 minutes
Antigen Retrieval:
Formaldehyde is a commonly used fixative. However, it causes protein linkages,
which may result in masking of tissue antigens. Antigen retrieval is
pre-treatment prior to immuno-staining used to unmask the antigen. The
technique involves use of proteolytic enzyme digestion of heat induced antigen
retrieval method.
Primary Antibody: after
antigen retrieval incubate the sample with blocking serum for 5 minutes. A
respective primary antibody should be added against the respective antigen.
This primary antibody is used as a monoclonal antibody which is able to detect
only 1 antigen. The antigen is incubated with primary antibody for one hour.
Secondary Antibody: Secondary
antibody is mainly used in indirect ELISA test. In this test secondary antibodies
provide structural support. Due to the structural bond between 1° and 2° antibody, the washing
agent unable to break down the bond between them. A enzyme (HRP) labelled with
secondary antibody incubate for 20-30 minutes.
Substrate Chromogen System:
A TMB substrate is added to the sample which reacts with Horse reddish
Peroxidase (HRP) enzyme and gives an instant colour in an alkaline medium. The
intensity of the colour is directly proportional to the concentration of the
antigen present in the sample. Apply chromogen substrate for 5-10 minutes.
Counter Staining: After chromogen substrate system
a second chemical stain is other applied to provide contrast that helps the
primary staining product stand out. The most used counterstain in IHC is Dab,
Hematoxylin & Eosin (H&E), Thermo-scientific pierce Hoechst
fluorescent stain etc.
Observation: After staining procedure the slide is mounted
by DPX and Canada Balsam, therefore the slide observes under the electric
microscope at 100x by using cedar wood oil for better visualization.
Diagnostic
Immunohistochemistry Markers:
Immunohistochemistry (IHC) is
an excellent detection technique and has the tremendous advantage of being able
to show exactly where a given protein is located within the tissue examined. It
is also an effective way to examine the tissue. IHC has become a widely used
technique in the neurosciences, enabling researches to examine protein
expressions within specific brain structures. Its major disadvantage is that,
unlike immunoblotting technique where staining is checked against a molecular
weight ladder it is possible to show in IHC that the staining is corresponded
with the antigen of interest. For this reason, the primary antibodies must be
well validated in a western blot on similar procedure. IHC technique is more
widely used in diagnostic pathology for typing tumours, e.g., Immunostaining
for e-cadherin (adhesive molecule) to differentiate between DCIS (ductal
carcinoma in situ, stains positive) and LCIS (lobular carcinoma in situ, which
does not stain positive).
Most recently IHC have been
useful in differential diagnosis of multiple forms of salivary gland, head,
neck carcinomas.
Following is some test used
in Immunohistochemistry –
1.Identification of B cell
lymphomas using CD20
2. Identification of T cell
lymphomas using CD3
3. CD45 and CD30 used in
Hodgkin’s disease
4.CD117 used for
gastrointestinal stromal tumours.
5.CD10(CALLA) used for renal
cell carcinoma and acute lymphoblastic leukaemia
6.Prostat specific antigen
used for PROSTAT gland.
7.Cytokeratins used for
identification of carcinomas.
8.Estrogens and Progesterone
staining for tumour identification.
Chemical
Inhibitors for Immunohistochemistry (IHC):
Tumor biology allows for a
number of potential intracellular targets. Many tumors are hormone dependent.
The presence of hormone receptors can be used to determine if a tumor is
potentially responsive to antimonial therapy. One of the first therapies was
the antioestrogen, tamoxifen, used to treat breast cancer such hormone receptors
can be detected by IHC. Imatinib, an intracellular tyrosine kinase inhibitor
was developed to trear chronic myelogenous lukemia, a disease characterised by
the formation of a specific abnormal tyrosine kinase. Imatinib has proven
effective in tumors that express other tyrosine kinase. Most notably KIT. Most
gastrointestinal stromal tumors express KIT. Which can be deleted by
Immunohistochemistry.
Clinical Significance:
IHC is a method
for detecting antigens or haptens in cells of a tissue section by exploiting
the principle of antibodies binding specifically to antigens in biological
tissues. IHC used for diagnosis of cancer, Specific tumor antigens are
expressed denovo or upregulated in certain cancers.
A positive test means that a marker or
receptor is bound on the cell during the biopsy or indicates a certain change
in the protein of the tumor.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)


